TIDMGSK
RNS Number : 1848M
GlaxoSmithKline PLC
06 May 2020
GlaxoSmithKline plc
Results of Annual General Meeting
GlaxoSmithKline plc ('GSK') held its Annual General Meeting
('AGM') at 2.30pm on Wednesday 6 May 2020.
As a result of the COVID-19 pandemic and the prohibition on
public gatherings of more than two people, the AGM was held as a
closed meeting attended by the minimum necessary quorum of two
shareholders. All valid proxy votes (whether submitted
electronically or in hard copy form) were included in the poll
taken at the meeting.
All resolutions were passed at the AGM and the results of the
poll are set out below. The full text of the resolutions considered
at the AGM are contained in the Notice of AGM published on 23 March
2020 which is available on GSK's website at www.gsk.com .
Commenting after the shareholder webcast, which was held after
the AGM, Sir Jonathan Symonds, Chairman, said "Despite the current
crisis which unfortunately meant that we could not hold our AGM in
the usual way, I was pleased that we could engage with our
shareholders via the webcast and that we were able to answer a
number of questions. I would like to thank shareholders for their
participation and for their continued support and understanding in
these exceptional times".
Resolution Total votes % Total % Total votes Votes
for (1)(2) votes against cast withheld
(2) (3)
Receive and adopt
the 2019 Annual
1 Report 3,600,444,466 99.14 31,207,913 0.86 3,631,652,379 10,956,841
------------------------ -------------- ------ --------------- ------ -------------- ------------
Approve the Annual
2 report on remuneration 3,420,333,315 94.53 197,813,171 5.47 3,618,146,486 24,463,063
------------------------ -------------- ------ --------------- ------ -------------- ------------
To approve the
3 Remuneration policy 2,665,161,732 88.18 357,360,021 11.82 3,022,521,753 620,087,463
------------------------ -------------- ------ --------------- ------ -------------- ------------
Election of Sir
4 Jonathan Symonds 3,608,718,661 99.35 23,502,289 0.65 3,632,220,950 10,386,063
------------------------ -------------- ------ --------------- ------ -------------- ------------
Election of Charles
5 Bancroft 3,627,334,204 99.87 4,856,095 0.13 3,632,190,299 10,417,951
------------------------ -------------- ------ --------------- ------ -------------- ------------
Re-election of
6 Emma Walmsley 3,627,591,812 99.84 5,958,848 0.16 3,633,550,660 9,058,990
------------------------ -------------- ------ --------------- ------ -------------- ------------
Re-election of
7 Vindi Banga 3,610,251,798 99.39 22,061,718 0.61 3,632,313,516 10,290,761
------------------------ -------------- ------ --------------- ------ -------------- ------------
Re-election of
8 Dr Hal Barron 3,626,272,920 99.83 6,065,354 0.17 3,632,338,274 10,268,248
------------------------ -------------- ------ --------------- ------ -------------- ------------
Re-election of
9 Dr Vivienne Cox 3,610,563,927 99.39 21,999,262 0.61 3,632,563,189 10,044,077
------------------------ -------------- ------ --------------- ------ -------------- ------------
Re-election of
10 Lynn Elsenhans 3,625,704,253 99.82 6,692,345 0.18 3,632,396,598 10,211,321
------------------------ -------------- ------ --------------- ------ -------------- ------------
Re-election of
11 Dr Laurie Glimcher 3,627,888,440 99.87 4,570,015 0.13 3,632,458,455 10,149,465
------------------------ -------------- ------ --------------- ------ -------------- ------------
Re-election of
12 Dr Jesse Goodman 3,627,512,409 99.87 4,791,872 0.13 3,632,304,281 10,303,639
------------------------ -------------- ------ --------------- ------ -------------- ------------
Re-election of
13 Judy Lewent 3,555,987,248 97.90 76,330,162 2.10 3,632,317,410 10,290,509
------------------------ -------------- ------ --------------- ------ -------------- ------------
Re-election of
14 Iain Mackay 3,589,348,335 98.83 42,624,938 1.17 3,631,973,273 10,634,976
------------------------ -------------- ------ --------------- ------ -------------- ------------
Re-election of
15 Urs Rohner 3,566,736,006 98.27 62,967,560 1.73 3,629,703,566 10,694,898
------------------------ -------------- ------ --------------- ------ -------------- ------------
Re-appointment
16 of the auditor 3,629,594,188 99.89 4,085,942 0.11 3,633,680,130 8,926,613
------------------------ -------------- ------ --------------- ------ -------------- ------------
Remuneration of
17 auditor 3,628,076,303 99.86 4,927,253 0.14 3,633,003,556 9,605,108
------------------------ -------------- ------ --------------- ------ -------------- ------------
Authority for the
company to make
donations to political
organisations and
incur political
18 expenditure 3,535,034,521 97.51 90,339,692 2.49 3,625,374,213 17,230,899
------------------------ -------------- ------ --------------- ------ -------------- ------------
Authority to allot
19 shares 3,486,912,340 96.08 142,428,115 3.92 3,629,340,455 13,259,348
------------------------ -------------- ------ --------------- ------ -------------- ------------
Disapplication
of pre-emption
rights - general
20 power (4) 3,551,097,589 97.88 76,802,232 2.12 3,627,899,821 14,698,767
------------------------ -------------- ------ --------------- ------ -------------- ------------
Disapplication
of pre-emption
rights - in connection
with an acquisition
or specified capital
21 investment (4) 3,547,842,037 97.88 76,869,347 2.12 3,624,711,384 17,887,616
------------------------ -------------- ------ --------------- ------ -------------- ------------
Authority for the
company to purchase
its own shares
22 (4) 3,564,497,165 98.16 66,913,063 1.84 3,631,410,228 11,196,094
------------------------ -------------- ------ --------------- ------ -------------- ------------
Exemption from
statement of senior
statutory auditor's
23 name 3,584,838,016 98.78 44,131,049 1.22 3,628,969,065 13,635,791
------------------------ -------------- ------ --------------- ------ -------------- ------------
Authority for reduced
notice of a general
meeting other than
24 an AGM (4) 3,354,669,411 92.41 275,453,838 7.59 3,630,123,249 12,478,713
------------------------ -------------- ------ --------------- ------ -------------- ------------
Notes:
(1) The "for" votes include those giving the Chairman discretion. In
line with the notification issued to American Depositary Receipt
(ADR) holders last year, GSK did not instruct its ADR Depositary
to vote any unvoted ADRs in respect of the AGM resolutions.
(2) Votes "for" and "against" are expressed as a percentage of the
total votes cast.
(3) A vote withheld is not a vote in law and is not counted in the
calculation of the proportion of votes "for" or "against" a resolution.
(4) Indicates Special Resolutions requiring a 75% majority.
The following table provides further relevant information:
GSK's GSK's
Twentieth Nineteenth
AGM AGM
(2020) (2019)
Issued share capital (excluding Treasury Shares) 5,017,091,542 4,987,806,108
-------------- --------------
Total votes cast and votes withheld lodged as
a % of GSK's issued share capital (excluding
Treasury Shares) 72.60% 71.49%
-------------- --------------
Total shareholder population 105,353 108,698
-------------- --------------
Total number of proxies lodged 6,268 6,635
-------------- --------------
% of shareholders who lodged proxies 5.95% 6.10%
-------------- --------------
The above poll results will shortly be available on the
Company's website at www.gsk.com . In accordance with Listing Rule
9.6.2, a copy of the resolutions, other than those concerning
ordinary business, will be submitted to the UK Listing Authority
and will in due course be available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
V A Whyte
Company Secretary
6 May 2020
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
RAGKKABNABKDAPK
(END) Dow Jones Newswires
May 06, 2020 12:40 ET (16:40 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
